Clinical Trials Directory

Trials / Unknown

UnknownNCT05794529

Lung Tumor Protein Synthesis Rates in Lung Cancer Patients

Characterizing Tissue Protein Synthesis Rates of Non-small Cell Lung Carcinomas in Lung Cancer Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers

Summary

The current study will recruit lung cancer patients to measure tissue protein synthesis rates of non-small cell lung carcinomas and healthy lung tissue. The protein synthesis rates of healthy lung tissue will be compared to lung tumor tissue to establish the remodeling characteristics of healthy versus cancerous lung tissues. We will also examine whether tissue protein synthesis rates of non-small cell lung carcinomas are associated with various tumor- (i.e., size, subclassification) and patient-derived (i.e., inflammation, lung function, smoking status, and smoking history) parameters.

Conditions

Interventions

TypeNameDescription
OTHERThere are no interventions in the present studyThere are no interventions in the present study

Timeline

Start date
2023-03-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2023-04-03
Last updated
2023-04-03

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05794529. Inclusion in this directory is not an endorsement.